軟骨変性の世界市場レポート 2024年

軟骨変性の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.5%の年間複合成長率（CAGR）で156億4,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、再生医療の進歩、生物製剤注射の使用、組織工学におけるソリューション、精密医療の導入、ロボット支援手術の統合によるものと考えられます。予測期間中に予想される主要動向には、幹細胞治療の採用、整形外科における3Dプリンティングの応用、軟骨修復のための遺伝子治療の利用、個別化されたリハビリテーションプログラムの開発、フォローアップケアのための遠隔医療の組み込みなどが含まれます。

軟骨変性市場の予想される成長は、肥満の有病率の増加によって促進されると予想されます。肥満は体脂肪の過剰な蓄積を特徴とする病状であり、個人の健康にリスクをもたらし、軟骨変性の開始と加速に寄与する可能性があります。これは主に、軟骨圧縮力の上昇と炎症性サイトカインの放出に起因すると考えられます。肥満は、異常な負荷、関節の不正配列、筋力低下など、膝関節構造全体にさまざまな病理学的変化を引き起こします。 2023年5月に政府デジタルサービスが報告したように、2021年から2022年にかけて英国の18歳以上の成人の約63.8％が過体重または肥満を抱えた状態であり、前年の63.3％から増加しました。成人のうち、推定25.9%が肥満と分類され、2020年から2021年にかけて25.2%増加しました。その結果、肥満の有病率の上昇が軟骨変性市場の成長の主要原動力となっています。

高齢者人口の増加も軟骨変性市場の拡大に寄与すると予想されます。 65歳以上の高齢者は、加齢に伴う筋肉量や骨量の減少を経験し、衰弱や筋力の低下につながります。 軟骨変性に対処することは、この人口統計グループの筋肉、骨、関節の加齢に伴う変化を防ぎ、骨を強化し、骨量減少のペースを遅らせる上で重要な役割を果たすことができます。世界保健機関（WHO）は、60歳以上の人口が2020年の10億人から2030年までに14億人、2050年までに21億人に大幅に増加すると予測しています。さらに、80歳以上の人口はしたがって、高齢者人口の増加は、軟骨変性市場の成長を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の軟骨変性市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の軟骨変性の市場規模実績と成長、2018～2023年
• 世界の軟骨変性市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の軟骨変性市場、施術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 関節置換術
• 軟骨形成術
• 骨軟骨移植
• 微小破壊
• 半月板移植
• 細胞ベースの軟骨表面再生
• 自家軟骨細胞移植
• その他
• 世界の軟骨変性市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 膝
• 腰
• その他
• 世界の軟骨変性市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院と専門クリニック
• 外来手術センター
• 学術研究機関

第7章 地域と国の分析

• 世界の軟骨変性市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の軟骨変性市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 軟骨変性市場の競合情勢
• 軟骨変性市場の企業プロファイル
  • Johnson &Johnson Services Inc.
  • MEDIPOST Co. Ltd.
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.

第31章 その他の大手と革新的な企業

• Smith and Nephew plc
• B Braun Melsungen AG
• Osiris Therapeutics Inc.
• Arthrex Inc.
• Conmed Corporation
• Orthocell Ltd.
• Bioventus LLC
• Aesculap Inc.
• Vericel Corporation
• Anika Therapeutics Inc.
• Geistlich Pharma AG
• MatTek Corporation
• Breg Inc.
• Isto Biologics Inc.
• OrthoTrophix LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Cartilage degeneration is the gradual deterioration or breakdown of the smooth, flexible connective tissue known as cartilage, which covers the ends of bones in joints. Cartilage serves as a cushion, facilitating smooth joint movement by reducing friction between bones. The degeneration of cartilage results in pain, stiffness, and a decline in joint function.

The primary procedures for addressing cartilage degeneration include joint replacements, chondroplasty, osteochondral transplants, microfracture, meniscus transplants, cell-based cartilage resurfacing, autologous chondrocyte implantation, and other related interventions. Joint replacements involve a surgical process where a damaged or diseased joint is substituted with an artificial joint, commonly referred to as a prosthesis. These procedures are applicable to various joints such as the knee, hip, and others. They are performed in diverse healthcare settings, including hospitals, specialty clinics, ambulatory surgical centers, and academic and research institutes.

The cartilage degeneration market research report is one of a series of new reports from The Business Research Company that provides cartilage degeneration market statistics, including cartilage degeneration industry global market size, regional shares, competitors with a cartilage degeneration market share, detailed cartilage degeneration market segments, market trends and opportunities, and any further data you may need to thrive in the cartilage degeneration industry. This cartilage degeneration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cartilage degeneration market size has grown strongly in recent years. It will grow from $11.88 billion in 2023 to $12.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The expansion observed in the historical period can be ascribed to factors such as an aging population, incidents of joint injuries, the prevalence of the obesity epidemic, sports-related injuries, and the restricted self-repair capacity of cartilage.

The cartilage degeneration market size is expected to see strong growth in the next few years. It will grow to $15.64 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The anticipated growth in the forecast period can be ascribed to advancements in regenerative medicine, the use of biologic injections, solutions in tissue engineering, the implementation of precision medicine, and the integration of robotics-assisted surgery. Key trends expected during the forecast period encompass the adoption of stem cell therapies, the application of 3D printing in orthopedics, the utilization of gene therapy for cartilage repair, the development of personalized rehabilitation programs, and the incorporation of telemedicine for follow-up care.

The anticipated growth of the cartilage degeneration market is expected to be propelled by the increasing prevalence of obesity. Obesity, a medical condition characterized by the excessive accumulation of body fat, poses a risk to an individual's health and can contribute to the initiation and acceleration of cartilage degeneration. This is primarily attributed to heightened cartilage compressive forces and the release of inflammatory cytokines. Obesity induces various pathological changes in the entire knee joint structure, including abnormal loading, joint malalignment, and muscle weakness. As reported by the Government Digital Service in May 2023, approximately 63.8% of adults aged 18 years and over in the UK were overweight or living with obesity in 2021-2022, reflecting an increase from 63.3% the previous year. Among adults, an estimated 25.9% were classified as obese, marking a 25.2% increase from 2020 to 2021. Consequently, the rising prevalence of obesity is a key driver of the cartilage degeneration market's growth.

The growing elderly population is also expected to contribute to the expansion of the cartilage degeneration market. The elderly population, comprising individuals aged 65 years or older, experiences age-related muscle and bone mass loss, leading to weakness and reduced strength. Addressing cartilage degeneration can play a vital role in preventing age-related changes in muscles, bones, and joints, strengthening bones, and delaying the pace of bone loss in this demographic group. The World Health Organization (WHO) projects a significant increase in the number of individuals aged 60 years or older, from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, the number of people aged 80 years or older is expected to triple from 143 million in 2020 to 426 million in 2050. Thus, the growing elderly population is a significant factor driving the growth of the cartilage degeneration market.

Prominent companies in the cartilage degeneration market are actively engaged in the development of innovative products, exemplified by the creation of Agili-C, designed to facilitate bone remodeling and cartilage regeneration. Agili-C stands out as a cell-free, off-the-shelf implant crafted for repairing cartilage and osteochondral defects prevalent in traumatic and osteoarthritic joints. In a notable development reported in July 2023, CartiHeal Ltd., an Israel-based medical device company, celebrated the first commercial implantation of Agili-C. The implant's distinctive approach aims to stimulate the natural process of articular cartilage and subchondral bone regeneration without relying on cells or growth factors. Crafted from natural calcium carbonate (aragonite) sourced from coral exoskeletons, the implant prompts the migration of chondrocytes from surrounding cartilage into the scaffold, facilitating the deposition of an extracellular matrix. This achievement enhances the implant's credibility by assuring patients and healthcare providers of its safety and effectiveness.

Major companies operating in the cartilage degeneration sector are prioritizing the development of cutting-edge technologies. A notable example comes from August 2021 when Zimmer Biomet, a US-based medical technology company, and Canary Medical Inc., a US-based medical data company, jointly introduced Persona IQ knee implant - the world's inaugural smart knee implant designed for total knee replacement surgery. Distinguishing itself, Persona IQ combines Zimmer Biomet's established knee implant, Persona The Personalized Knee, with Canary Medical's proprietary implantable canturioTMte tibial extension sensor technology. This technology measures and assesses various gait metrics, including range of motion, step count, and walking speed. Persona IQ captures this data and wirelessly communicates it to a patient's personal base station at home, enabling healthcare providers to monitor post-operative recovery status through a cloud-based platform.

In July 2022, Bioventus Inc., a US-based company specializing in active healing and surgical Ortho biologics, successfully acquired CartiHeal for $315 million. This strategic acquisition positions Bioventus to augment its joint preservation technologies, supporting short- and mid-term growth objectives and aligning with its ongoing pursuit of sustained double-digit revenue growth. CartiHeal Ltd., the acquired entity, is an Israel-based medical device company at the forefront of developing and commercializing proprietary implants to address cartilage and osteochondral defects in traumatic and osteoarthritic joints.

Major companies operating in the cartilage degeneration market report are Johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew plc, B Braun Melsungen AG, Osiris Therapeutics Inc., Arthrex Inc., Conmed Corporation, Orthocell Ltd., Bioventus LLC, Aesculap Inc., Vericel Corporation, Anika Therapeutics Inc., Geistlich Pharma AG, MatTek Corporation, Breg Inc., Isto Biologics Inc., OrthoTrophix LLC, CellGenix GmbH, CartiHeal Inc., Cayenne Medical Inc., Collagen Solutions plc, Regentis Biomaterials Ltd., Histogen Inc., BioTime Inc., CollPlant Holdings Ltd.,,

North America was the largest region in the cartilage degeneration market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cartilage degeneration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cartilage degeneration market consists of revenues earned by entities by provide services such as diagnosis and evaluation, non-surgical management, patient education, physical therapy, and nutritional and lifestyle guidance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cartilage degeneration market also includes sales of over-the-counter medications, joint supplements, topical pain relievers, and hyaluronic acid injections. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cartilage Degeneration Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cartilage degeneration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cartilage degeneration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cartilage degeneration market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Procedure: Joint Replacements; Chondroplasty; Osteochondral Transplants; Microfracture; Meniscus Transplants; Cell-Based Cartilage Resurfacing; Autologous Chondrocyte Implantation; Other Procedures
• 2) By Application: Knee; Hip; Other Applications
• 3) By End User: Hospitals And Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes
• Companies Mentioned: Johnson & Johnson Services Inc.; MEDIPOST Co. Ltd.; Medtronic plc; Stryker Corporation; Zimmer Biomet Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cartilage Degeneration Market Characteristics

3. Cartilage Degeneration Market Trends And Strategies

4. Cartilage Degeneration Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Cartilage Degeneration Market Size and Growth

• 5.1. Global Cartilage Degeneration Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Cartilage Degeneration Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Cartilage Degeneration Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cartilage Degeneration Market Segmentation

• 6.1. Global Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Joint Replacements
• Chondroplasty
• Osteochondral Transplants
• Microfracture
• Meniscus Transplants
• Cell-Based Cartilage Resurfacing
• Autologous Chondrocyte Implantation
• Other Procedures
• 6.2. Global Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Knee
• Hip
• Other Applications
• 6.3. Global Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Specialty Clinics
• Ambulatory Surgical Centers
• Academic And Research Institutes

7. Cartilage Degeneration Market Regional And Country Analysis

• 7.1. Global Cartilage Degeneration Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Cartilage Degeneration Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cartilage Degeneration Market

• 8.1. Asia-Pacific Cartilage Degeneration Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cartilage Degeneration Market

• 9.1. China Cartilage Degeneration Market Overview
• 9.2. China Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cartilage Degeneration Market

• 10.1. India Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cartilage Degeneration Market

• 11.1. Japan Cartilage Degeneration Market Overview
• 11.2. Japan Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cartilage Degeneration Market

• 12.1. Australia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cartilage Degeneration Market

• 13.1. Indonesia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cartilage Degeneration Market

• 14.1. South Korea Cartilage Degeneration Market Overview
• 14.2. South Korea Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cartilage Degeneration Market

• 15.1. Western Europe Cartilage Degeneration Market Overview
• 15.2. Western Europe Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cartilage Degeneration Market

• 16.1. UK Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cartilage Degeneration Market

• 17.1. Germany Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cartilage Degeneration Market

• 18.1. France Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cartilage Degeneration Market

• 19.1. Italy Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cartilage Degeneration Market

• 20.1. Spain Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cartilage Degeneration Market

• 21.1. Eastern Europe Cartilage Degeneration Market Overview
• 21.2. Eastern Europe Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cartilage Degeneration Market

• 22.1. Russia Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cartilage Degeneration Market

• 23.1. North America Cartilage Degeneration Market Overview
• 23.2. North America Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cartilage Degeneration Market

• 24.1. USA Cartilage Degeneration Market Overview
• 24.2. USA Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cartilage Degeneration Market

• 25.1. Canada Cartilage Degeneration Market Overview
• 25.2. Canada Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cartilage Degeneration Market

• 26.1. South America Cartilage Degeneration Market Overview
• 26.2. South America Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cartilage Degeneration Market

• 27.1. Brazil Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cartilage Degeneration Market

• 28.1. Middle East Cartilage Degeneration Market Overview
• 28.2. Middle East Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cartilage Degeneration Market

• 29.1. Africa Cartilage Degeneration Market Overview
• 29.2. Africa Cartilage Degeneration Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Cartilage Degeneration Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Cartilage Degeneration Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cartilage Degeneration Market Competitive Landscape And Company Profiles

• 30.1. Cartilage Degeneration Market Competitive Landscape
• 30.2. Cartilage Degeneration Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. MEDIPOST Co. Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Medtronic plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Stryker Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Zimmer Biomet Holdings Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Cartilage Degeneration Market Other Major And Innovative Companies

• 31.1. Smith and Nephew plc
• 31.2. B Braun Melsungen AG
• 31.3. Osiris Therapeutics Inc.
• 31.4. Arthrex Inc.
• 31.5. Conmed Corporation
• 31.6. Orthocell Ltd.
• 31.7. Bioventus LLC
• 31.8. Aesculap Inc.
• 31.9. Vericel Corporation
• 31.10. Anika Therapeutics Inc.
• 31.11. Geistlich Pharma AG
• 31.12. MatTek Corporation
• 31.13. Breg Inc.
• 31.14. Isto Biologics Inc.
• 31.15. OrthoTrophix LLC

32. Global Cartilage Degeneration Market Competitive Benchmarking

33. Global Cartilage Degeneration Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cartilage Degeneration Market

35. Cartilage Degeneration Market Future Outlook and Potential Analysis

• 35.1 Cartilage Degeneration Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Cartilage Degeneration Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Cartilage Degeneration Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer